Liminatus Pharma, Inc. (LIMN)
$4.67-9.50%Close
SELLCRISIS · day 4
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $125M
- Avg volume
- 603.5K
- Beta
- 0.74
- P/E (TTM)
- -0.21
- Short % float
- 52.44%
- Days to cover
- 1.0
- SI change
- +76.1%
- 1W
- -33.95%
- 1M
- -15.86%
- 3M
- -44.86%
- YTD
- -85.42%
- vs SPY 1W
- -32.76%
- vs SPY 1M
- -19.18%
- vs SPY 3M
- -47.26%
- vs SPY YTD
- -97.18%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- XBIOBUYXenetic Biosciences, Inc.RECOVERYQ -8$3.81+6.13%
- RMTIBUYRockwell Medical, Inc.RECOVERYQ 6$7.90-2.47%
- RNXTBUYRenovoRx, Inc.RECOVERYQ -2$1.25-5.30%
- MSPRSELLMSP Recovery, Inc.RECOVERYQ -29$0.00
- SGHTBUYSight Sciences, Inc.RECOVERYQ -13$8.38+1.45%
- ISPCSELLiSpecimen Inc.CRISISQ -26$1.57-7.10%
- IBRXBUYImmunityBio, Inc.RECOVERYQ 7$7.58-2.70%
- BHVNSELLBiohaven Ltd.CRISISQ 19$13.68-1.23%
- CINGBUYCingulate Inc.RECOVERYQ -17$5.68+2.34%
- TNDMBUYTandem Diabetes Care, Inc.RECOVERYQ -7$22.22-0.45%
- CTMXBUYCytomX Therapeutics, Inc.RECOVERYQ 8$3.29+0.30%
- LCTXSELLLineage Cell Therapeutics, Inc.RECOVERYQ 11$1.09+0.93%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
